Lyra Therapeutics, Inc. (LYRA)

PNK – Real Time Price. Currency in USD

0.73

-0.01 (-1.22%)

Market open: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

398K

Cost of goods sold

-459K

-471K

-278K

-1M

Gross Profit

-61K

296K

Operating expenses (excl. COGS)

-29M

-62M

-67M

-55M

Operating Income

-30M

-61M

-66M

-55M

Non-operating income, total

645K

-33M

-275K

Pretax income

-29M

-93M

-63M

-55M

Equity in earnings

Taxes

-11K

-39K

-59K

-13K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-29M

-93M

-63M

-55M

Lyra Therapeutics, Inc. (LYRA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Lyra Therapeutics, Inc. (LYRA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Lyra Therapeutics, Inc. (LYRA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Lyra Therapeutics, Inc. (LYRA)

Income Statement (Annual)

Income Statement (Annual)